249 related articles for article (PubMed ID: 22812247)
41. Evaluation of the diagnostic efficacy of
Niyonkuru A; Chen X; Bakari KH; Wimalarathne DN; Bouhari A; Arnous MMR; Lan X
Cancer Med; 2020 Feb; 9(3):931-942. PubMed ID: 31837121
[TBL] [Abstract][Full Text] [Related]
42. A model of malignant risk prediction for solitary pulmonary nodules on
Yu M; Wang Z; Yang G; Cheng Y
Thorac Cancer; 2020 May; 11(5):1211-1215. PubMed ID: 32162769
[TBL] [Abstract][Full Text] [Related]
43. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography.
Herder GJ; van Tinteren H; Golding RP; Kostense PJ; Comans EF; Smit EF; Hoekstra OS
Chest; 2005 Oct; 128(4):2490-6. PubMed ID: 16236914
[TBL] [Abstract][Full Text] [Related]
44. Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.
Grgic A; Yüksel Y; Gröschel A; Schäfers HJ; Sybrecht GW; Kirsch CM; Hellwig D
Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1087-94. PubMed ID: 20140611
[TBL] [Abstract][Full Text] [Related]
45. Predictive value of F-18 FDG PET/CT for malignant pleural effusion in non-small cell lung cancer patients.
Kim BS; Kim IJ; Kim SJ; Pak K; Kim K
Onkologie; 2011; 34(6):298-303. PubMed ID: 21625182
[TBL] [Abstract][Full Text] [Related]
46. (18)F-FDG-PET/CT in the assessment of pulmonary solitary nodules: comparison of different analysis methods and risk variables in the prediction of malignancy.
van Gómez López O; García Vicente AM; Honguero Martínez AF; Jiménez Londoño GA; Vega Caicedo CH; León Atance P; Soriano Castrejón ÁM
Transl Lung Cancer Res; 2015 Jun; 4(3):228-35. PubMed ID: 26207210
[TBL] [Abstract][Full Text] [Related]
47. [Diagnostic value of (18)F-FDG PET/CT for solitary nodular-type bronchoalveolar carcinoma].
Liu WK; Li XD; Quan JT; Ouyang X; Zheng H
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):114-6. PubMed ID: 25613623
[TBL] [Abstract][Full Text] [Related]
48. Risk-related
Spadafora M; Pace L; Evangelista L; Mansi L; Del Prete F; Saladini G; Miletto P; Fanti S; Del Vecchio S; Guerra L; Pepe G; Peluso G; Nicolai E; Storto G; Ferdeghini M; Giordano A; Farsad M; Schillaci O; Gridelli C; Cuocolo A
Eur J Nucl Med Mol Imaging; 2018 Oct; 45(11):1908-1914. PubMed ID: 29730697
[TBL] [Abstract][Full Text] [Related]
49. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules.
Swensen SJ; Silverstein MD; Ilstrup DM; Schleck CD; Edell ES
Arch Intern Med; 1997 Apr; 157(8):849-55. PubMed ID: 9129544
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging.
Bury T; Dowlati A; Paulus P; Corhay JL; Benoit T; Kayembe JM; Limet R; Rigo P; Radermecker M
Eur Respir J; 1996 Mar; 9(3):410-4. PubMed ID: 8729997
[TBL] [Abstract][Full Text] [Related]
51. Development and validation of a nomogram to estimate the pretest probability of cancer in Chinese patients with solid solitary pulmonary nodules: A multi-institutional study.
She Y; Zhao L; Dai C; Ren Y; Jiang G; Xie H; Zhu H; Sun X; Yang P; Chen Y; Shi S; Shi W; Yu B; Xie D; Chen C
J Surg Oncol; 2017 Nov; 116(6):756-762. PubMed ID: 28570780
[TBL] [Abstract][Full Text] [Related]
52. Solitary pulmonary nodules: clinical prediction model versus physicians.
Swensen SJ; Silverstein MD; Edell ES; Trastek VF; Aughenbaugh GL; Ilstrup DM; Schleck CD
Mayo Clin Proc; 1999 Apr; 74(4):319-29. PubMed ID: 10221459
[TBL] [Abstract][Full Text] [Related]
53. Development and Validation of a
Guo HY; Lin JT; Huang HH; Gao Y; Yan MR; Sun M; Xu WP; Yan HH; Zhong WZ; Yang XN
Clin Lung Cancer; 2020 Jan; 21(1):47-55. PubMed ID: 31474376
[TBL] [Abstract][Full Text] [Related]
54. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
Wahidi MM; Govert JA; Goudar RK; Gould MK; McCrory DC;
Chest; 2007 Sep; 132(3 Suppl):94S-107S. PubMed ID: 17873163
[TBL] [Abstract][Full Text] [Related]
55. A Modified Model for Preoperatively Predicting Malignancy of Solitary Pulmonary Nodules: An Asia Cohort Study.
Zheng B; Zhou X; Chen J; Zheng W; Duan Q; Chen C
Ann Thorac Surg; 2015 Jul; 100(1):288-94. PubMed ID: 26037540
[TBL] [Abstract][Full Text] [Related]
56. Establishment of a mathematic model for predicting malignancy in solitary pulmonary nodules.
Zhang M; Zhuo N; Guo Z; Zhang X; Liang W; Zhao S; He J
J Thorac Dis; 2015 Oct; 7(10):1833-41. PubMed ID: 26623107
[TBL] [Abstract][Full Text] [Related]
57. Use of a decision analysis model to assess the medicoeconomic implications of FDG PET imaging in diagnosing a solitary pulmonary nodule.
Lejeune C; Al Zahouri K; Woronoff-Lemsi MC; Arveux P; Bernard A; Binquet C; Guillemin F
Eur J Health Econ; 2005 Sep; 6(3):203-14. PubMed ID: 15834623
[TBL] [Abstract][Full Text] [Related]
58. Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules.
Schultz EM; Sanders GD; Trotter PR; Patz EF; Silvestri GA; Owens DK; Gould MK
Thorax; 2008 Apr; 63(4):335-41. PubMed ID: 17965070
[TBL] [Abstract][Full Text] [Related]
59. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 1: radiologic characteristics and imaging modalities.
Patel VK; Naik SK; Naidich DP; Travis WD; Weingarten JA; Lazzaro R; Gutterman DD; Wentowski C; Grosu HB; Raoof S
Chest; 2013 Mar; 143(3):825-839. PubMed ID: 23460160
[TBL] [Abstract][Full Text] [Related]
60. Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy.
Pasha AK; Walsh TK; Ampel NM
Lung; 2015 Oct; 193(5):863-4. PubMed ID: 26202257
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
